Compounded GLP-1 medications have not undergone FDA premarket approval for safety, effectiveness, or quality as finished products
NICE Technology Appraisal guidance (TA875 for semaglutide/Wegovy and TA664 for liraglutide/Saxenda) recommends these medications for weight management in adults with: A body mass index (BMI) of at least 35 kg/m and At least one weight-related comorbidity (such as type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea, or non-alcoholic fatty liver disease) For liraglutide (Saxenda), NICE TA664 specifies additional criteria including prediabetes (HbA1c 42-47 mmol/mol or fasting plasma glucose 5.5-6.9 mmol/L) or high risk of cardiovascular disease
Y., Cao, S
In the spot, Williams shares the health benefits shes experienced since taking GLP-1s, including losing 34 pounds in a year, reduced knee joint stress, steady blood sugar, and lowered cholesterol
we of course need to be careful with the claims since addiction can display itself in such terrible ways
And like many medications, Ozempic can cause side effects
